Molecular and cellular analysis of human histamine receptor subtypes.
暂无分享,去创建一个
[1] L. Palmqvist,et al. Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells , 2012, Haematologica.
[2] R. Leurs,et al. Analysis of Multiple Histamine H4 Receptor Compound Classes Uncovers Gαi Protein- and β-Arrestin2-Biased Ligands , 2012, Molecular Pharmacology.
[3] R. Seifert,et al. Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils. , 2012, Biochemical pharmacology.
[4] J. Azorin,et al. Clozapine for the treatment of schizophrenia , 2012, Expert opinion on pharmacotherapy.
[5] R. Seifert,et al. Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations. , 2012, Biochemical pharmacology.
[6] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[7] M. Grimm,et al. Prognostic value of histamine H1 receptor expression in oral squamous cell carcinoma , 2012, Clinical Oral Investigations.
[8] W. Lamers,et al. Specificity evaluation of antibodies against human β3-adrenoceptors , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[9] R. Seifert,et al. Problems associated with the use of commercial and non-commercial antibodies against the histamine H4 receptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[10] C. Rhee,et al. Histamine regulates mucin expression through H1 receptor in airway epithelial cells , 2012, Acta oto-laryngologica.
[11] T. Kuroishi,et al. Histamine reduces susceptibility to natural killer cells via down‐regulation of NKG2D ligands on human monocytic leukaemia THP‐1 cells , 2012, Immunology.
[12] R. Leurs,et al. Well characterized antihistamine 4 receptor antibodies contribute to current knowledge of the expression and biology of the human and murine histamine 4 receptor , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[13] T. Kenakin. Biased signalling and allosteric machines: new vistas and challenges for drug discovery , 2012, British journal of pharmacology.
[14] R. Kiss,et al. Histamine H4 receptor ligands and their potential therapeutic applications: an update , 2012, Expert opinion on therapeutic patents.
[15] A. Falus,et al. Characterization and Function of Histamine Receptors in Human Bone Marrow Stromal Cells , 2012, Stem cells.
[16] N. Trier,et al. Production and characterization of peptide antibodies. , 2012, Methods.
[17] Wei Guo,et al. Potential role of store-operated Ca2+ entry in Th2 response induced by histamine in human monocyte-derived dendritic cells. , 2012, International immunopharmacology.
[18] A. Strasser,et al. Interactions of recombinant human histamine H1, H2, H3, and H4 receptors with 34 antidepressants and antipsychotics , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[19] R. Seifert,et al. The bivalent ligand approach leads to highly potent and selective acylguanidine-type histamine H₂ receptor agonists. , 2012, Journal of medicinal chemistry.
[20] Hans-Joachim Wittmann,et al. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R. , 2011, Biochemical pharmacology.
[21] R. Seifert,et al. Commercially available antibodies against human and murine histamine H4-receptor lack specificity , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.
[22] Hans-Joachim Wittmann,et al. Mepyramine-JNJ7777120-hybrid compounds show high affinity to hH(1)R, but low affinity to hH(4)R. , 2011, Bioorganic & medicinal chemistry letters.
[23] F. Ducancel,et al. Electroporation-aided DNA immunization generates polyclonal antibodies against the native conformation of human endothelin B receptor. , 2011, DNA and cell biology.
[24] A. Strasser,et al. Role of the second and third extracellular loops of the histamine H4 receptor in receptor activation , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.
[25] Hans-Joachim Wittmann,et al. Nα-Methylated phenylhistamines exhibit affinity to the hH4R—a pharmacological and molecular modelling study , 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.
[26] N. Takeda,et al. Involvement of Protein Kinase Cδ/Extracellular Signal-regulated Kinase/Poly(ADP-ribose) Polymerase-1 (PARP-1) Signaling Pathway in Histamine-induced Up-regulation of Histamine H1 Receptor Gene Expression in HeLa Cells* , 2011, The Journal of Biological Chemistry.
[27] Ruben Abagyan,et al. Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.
[28] C. Shayo,et al. Roles of Phosphorylation-dependent and -independent Mechanisms in the Regulation of Histamine H2 Receptor by G Protein-coupled Receptor Kinase 2* , 2011, The Journal of Biological Chemistry.
[29] R. Seifert,et al. Impact of fusion to Gαi2 and co‐expression with RGS proteins on pharmacological properties of human cannabinoid receptors CB1R and CB2R , 2011, The Journal of pharmacy and pharmacology.
[30] R. Gutzmer,et al. Pathogenetic and therapeutic implications of the histamine H4 receptor in inflammatory skin diseases and pruritus. , 2011, Frontiers in bioscience.
[31] J. Schwartz,et al. The histamine H3 receptor: from discovery to clinical trials with pitolisant , 2011, British journal of pharmacology.
[32] Lei Shi,et al. Attenuated expression of HRH4 in colorectal carcinomas: a potential influence on tumor growth and progression , 2011, BMC Cancer.
[33] M. Grimm,et al. Allergic Predisposition, Histamine and Histamine Receptor Expression (H1R, H2R) Are Associated with Complicated Courses of Sigmoid Diverticulitis , 2011, Journal of Gastrointestinal Surgery.
[34] R. Fass,et al. Pharmacological management of GERD: where does it stand now? , 2011, Trends in pharmacological sciences.
[35] N. Shankley,et al. The scientific legacy of Sir James W. Black. , 2011, Trends in pharmacological sciences.
[36] I. D. de Esch,et al. En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. , 2011, Trends in pharmacological sciences.
[37] S. Charlton,et al. Agonist-Biased Signaling at the Histamine H4 Receptor: JNJ7777120 Recruits β-Arrestin without Activating G Proteins , 2011, Molecular Pharmacology.
[38] A. Strasser,et al. Paradoxical Stimulatory Effects of the “Standard” Histamine H4-Receptor Antagonist JNJ7777120: the H4 Receptor Joins the Club of 7 Transmembrane Domain Receptors Exhibiting Functional Selectivity , 2011, Molecular Pharmacology.
[39] A. Newman-Tancredi,et al. Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties , 2011, Psychopharmacology.
[40] F. Carvalho,et al. Haematological toxicity of clozapine and some other drugs used in psychiatry , 2011, Human psychopharmacology.
[41] Corina I. García,et al. Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation* , 2011, The Journal of Biological Chemistry.
[42] Patrick Igel,et al. Histamine H4 receptor agonists. , 2010, Bioorganic & medicinal chemistry letters.
[43] R. Seifert,et al. Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors. , 2010, Pharmacology & therapeutics.
[44] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[45] A. Strasser,et al. Comparison of the pharmacological properties of human and rat histamine H(3)-receptors. , 2010, Biochemical pharmacology.
[46] Roland Seifert,et al. Structural Requirements for Inverse Agonism and Neutral Antagonism of Indole-, Benzimidazole-, and Thienopyrrole-Derived Histamine H4 Receptor Ligands , 2010, Journal of Pharmacology and Experimental Therapeutics.
[47] A. Magnan,et al. Histamine induces Th2 activation through the histamine receptor 1 in house dust mite rhinitic but not asthmatic patients , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[48] Wen Jiang,et al. Molecular Determinants of Ligand Binding to H4R Species Variants , 2010, Molecular Pharmacology.
[49] A. Strasser,et al. Impact of the DRY Motif and the Missing “Ionic Lock” on Constitutive Activity and G-Protein Coupling of the Human Histamine H4 Receptor , 2010, Journal of Pharmacology and Experimental Therapeutics.
[50] Keshava Rajagopal,et al. Teaching old receptors new tricks: biasing seven-transmembrane receptors , 2010, Nature Reviews Drug Discovery.
[51] D. Stechschulte,et al. Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells , 2010, Immunology.
[52] J. Bousquet,et al. Risk of first‐generation H1‐antihistamines: a GA2LEN position paper , 2010, Allergy.
[53] R. Seifert,et al. Modulation of histamine H3 receptor function by monovalent ions , 2010, Neuroscience Letters.
[54] R. Seifert,et al. No Evidence for Functional Selectivity of Proxyfan at the Human Histamine H3 Receptor Coupled to Defined Gi/Go Protein Heterotrimers , 2010, Journal of Pharmacology and Experimental Therapeutics.
[55] C. Akdis,et al. Histamine, histamine receptors and their role in immune pathology , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[56] A. Strasser,et al. Interactions of Histamine H1-Receptor Agonists and Antagonists with the Human Histamine H4-Receptor , 2009, Molecular Pharmacology.
[57] A. Strasser,et al. Synthesis and Structure−Activity Relationships of Cyanoguanidine-Type and Structurally Related Histamine H4 Receptor Agonists§ , 2009 .
[58] R. Seifert,et al. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands. , 2009, Biochemical pharmacology.
[59] M. Gillard,et al. H4 Histamine Receptors Mediate Cell Cycle Arrest in Growth Factor-Induced Murine and Human Hematopoietic Progenitor Cells , 2009, PloS one.
[60] Hans-Joachim Wittmann,et al. Contribution of Binding Enthalpy and Entropy to Affinity of Antagonist and Agonist Binding at Human and Guinea Pig Histamine H1-Receptor , 2009, Molecular Pharmacology.
[61] B. Jensen,et al. Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[62] P. Spano,et al. Should we be cautious on the use of commercially available antibodies to dopamine receptors? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[63] Wolfgang Kummer,et al. Suitability of muscarinic acetylcholine receptor antibodies for immunohistochemistry evaluated on tissue sections of receptor gene-deficient mice , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[64] R. Seifert,et al. N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent. , 2009, Journal of medicinal chemistry.
[65] Hans-Joachim Wittmann,et al. Molecular Basis for the Selective Interaction of Synthetic Agonists with the Human Histamine H1-Receptor Compared with the Guinea Pig H1-Receptor , 2009, Molecular Pharmacology.
[66] H. Stark,et al. The histamine H4 receptor is functionally expressed on T(H)2 cells. , 2009, The Journal of allergy and clinical immunology.
[67] Roland Seifert,et al. High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor. , 2009, Biochemistry.
[68] R. Seifert,et al. NG‐Acylated Aminothiazolylpropylguanidines as Potent and Selective Histamine H2 Receptor Agonists , 2009, ChemMedChem.
[69] R. Seifert,et al. Tritium‐Labeled N1‐[3‐(1H‐imidazol‐4‐yl)propyl]‐N2‐propionylguanidine ([3H]UR‐PI294), a High‐Affinity Histamine H3 and H4 Receptor Radioligand , 2009, ChemMedChem.
[70] N. F. Dabhoiwala,et al. Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[71] T. Wieland,et al. How reliable are G-protein-coupled receptor antibodies? , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[72] J. Velden,et al. Lack of specificity of antibodies directed against human beta-adrenergic receptors , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.
[73] Holger Stark,et al. Histamine H3 receptor antagonists go to clinics. , 2008, Biological & pharmaceutical bulletin.
[74] Jill M. Wetter,et al. cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia. , 2008, Journal of medicinal chemistry.
[75] R. Smits,et al. Discovery of quinazolines as histamine H4 receptor inverse agonists using a scaffold hopping approach. , 2008, Journal of medicinal chemistry.
[76] R. Seifert,et al. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. , 2008, Journal of medicinal chemistry.
[77] I. D. de Esch,et al. Phenylalanine 169 in the Second Extracellular Loop of the Human Histamine H4 Receptor Is Responsible for the Difference in Agonist Binding between Human and Mouse H4 Receptors , 2008, Journal of Pharmacology and Experimental Therapeutics.
[78] Hans-Joachim Wittmann,et al. Ligand-Specific Contribution of the N Terminus and E2-Loop to Pharmacological Properties of the Histamine H1-Receptor , 2008, Journal of Pharmacology and Experimental Therapeutics.
[79] Donard S Dwyer,et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection , 2008, Pharmacological Reviews.
[80] H. Haas,et al. Histamine in the nervous system. , 2008, Physiological reviews.
[81] Robert Kiss,et al. Activation Mechanism of the Human Histamine H4 Receptor - An Explicit Membrane Molecular Dynamics Simulation Study , 2008, J. Chem. Inf. Model..
[82] Hans-Joachim Wittmann,et al. Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms , 2008, Journal of Pharmacology and Experimental Therapeutics.
[83] B. Damaj,et al. Functional Expression of H4 Histamine Receptor in Human Natural Killer Cells, Monocytes, and Dendritic Cells , 2007, The Journal of Immunology.
[84] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[85] R. Seifert,et al. Point mutations in the second extracellular loop of the histamine H2 receptor do not affect the species-selective activity of guanidine-type agonists , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.
[86] H. de Haard,et al. Properties, production, and applications of camelid single-domain antibody fragments , 2007, Applied Microbiology and Biotechnology.
[87] M. Bouvier,et al. The evasive nature of drug efficacy: implications for drug discovery. , 2007, Trends in pharmacological sciences.
[88] Xavier Deupi,et al. Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.
[89] R. Leurs,et al. Histamine downregulates monocyte CCL2 production through the histamine H4 receptor. , 2007, The Journal of allergy and clinical immunology.
[90] R. Leurs,et al. In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists , 2007, Journal of Pharmacology and Experimental Therapeutics.
[91] R. Seifert,et al. Mutations of Cys-17 and Ala-271 in the Human Histamine H2 Receptor Determine the Species Selectivity of Guanidine-Type Agonists and Increase Constitutive Activity , 2007, Journal of Pharmacology and Experimental Therapeutics.
[92] M. Nishibori,et al. Histamine H4 receptor agonists have more activities than H4 agonism in antigen‐specific human T‐cell responses , 2007, Immunology.
[93] R. Seifert,et al. Constitutive Activity and Ligand Selectivity of Human, Guinea Pig, Rat, and Canine Histamine H2 Receptors , 2007, Journal of Pharmacology and Experimental Therapeutics.
[94] N. Takeda,et al. Stimulation of histamine H1 receptor up-regulates histamine H1 receptor itself through activation of receptor gene transcription. , 2007, Journal of pharmacological sciences.
[95] Arno Lukas,et al. Identification of discontinuous antigenic determinants on proteins based on shape complementarities , 2007, Journal of molecular recognition : JMR.
[96] Massimo Triggiani,et al. Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. , 2007, The Journal of allergy and clinical immunology.
[97] R. Seifert,et al. Effects of Impromidine‐ and Arpromidine‐Derived Guanidines on Recombinant Human and Guinea Pig Histamine H1 and H2 Receptors , 2007, Archiv der Pharmazie.
[98] R. Smits,et al. Discovery of S-(2-guanidylethyl)-isothiourea (VUF 8430) as a potent nonimidazole histamine H4 receptor agonist. , 2006, Journal of medicinal chemistry.
[99] Sun-Hee Kim,et al. Isoliquiritigenin Selectively Inhibits H2 Histamine Receptor Signaling , 2006, Molecular Pharmacology.
[100] T. Yoshino,et al. Cimetidine Induces Interleukin-18 Production through H2-Agonist Activity in Monocytes , 2006, Molecular Pharmacology.
[101] R. Smits,et al. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives. , 2006, Journal of medicinal chemistry.
[102] R. Thurmond,et al. The Histamine H4 Receptor Mediates Allergic Airway Inflammation by Regulating the Activation of CD4+ T Cells , 2006, The Journal of Immunology.
[103] R. Seifert,et al. N1-(3-Cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a Potent Partial Agonist for the Human Histamine H1- and H2-Receptors , 2006, Journal of Pharmacology and Experimental Therapeutics.
[104] J. Arrang,et al. Compared pharmacology of human histamine H3 and H4 receptors: structure–activity relationships of histamine derivatives , 2006, British journal of pharmacology.
[105] R. Seifert,et al. Probing Ligand-Specific Histamine H1- and H2-Receptor Conformations with NG-Acylated Imidazolylpropylguanidines , 2006, Journal of Pharmacology and Experimental Therapeutics.
[106] C. Ganellin,et al. Histamine and its receptors , 2006, British journal of pharmacology.
[107] Rob Leurs,et al. Evaluation of Histamine H1-, H2-, and H3-Receptor Ligands at the Human Histamine H4 Receptor: Identification of 4-Methylhistamine as the First Potent and Selective H4 Receptor Agonist , 2005, Journal of Pharmacology and Experimental Therapeutics.
[108] M. Greaves. Antihistamines in Dermatology , 2005, Skin Pharmacology and Physiology.
[109] H. Stark,et al. Histamine H4 Receptor Stimulation Suppresses IL-12p70 Production and Mediates Chemotaxis in Human Monocyte-Derived Dendritic Cells 1 , 2005, The Journal of Immunology.
[110] R. Leurs,et al. The histamine H3 receptor: from gene cloning to H3 receptor drugs , 2005, Nature Reviews Drug Discovery.
[111] Junmei Wang,et al. Development and testing of a general amber force field , 2004, J. Comput. Chem..
[112] M. Babina,et al. Human skin mast cells express H2 and H4, but not H3 receptors. , 2004, The Journal of investigative dermatology.
[113] R. Thurmond,et al. Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule upregulation , 2004, British journal of pharmacology.
[114] Lars Karlsson,et al. A Potent and Selective Histamine H4 Receptor Antagonist with Anti-Inflammatory Properties , 2004, Journal of Pharmacology and Experimental Therapeutics.
[115] D. Richel,et al. Activation of the Canonical β-Catenin Pathway by Histamine* , 2003, Journal of Biological Chemistry.
[116] Arthur Christopoulos,et al. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology , 2003, Pharmacological Reviews.
[117] T. Williams,et al. Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor , 2003, British journal of pharmacology.
[118] J. Schwartz,et al. Protean agonism at histamine H3 receptors in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[119] J. Williams,et al. Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone‐inducible mammalian expression system , 2003, British journal of pharmacology.
[120] C. Shayo,et al. Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model. , 2003, Molecular pharmacology.
[121] T. Bürckstümmer,et al. Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor , 2003, Journal of Pharmacology and Experimental Therapeutics.
[122] F. Gantner,et al. Histamine H4 and H2 Receptors Control Histamine-Induced Interleukin-16 Release from Human CD8+ T Cells , 2002, Journal of Pharmacology and Experimental Therapeutics.
[123] R. Seifert,et al. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.
[124] F. Monsma,et al. Molecular modeling and site-specific mutagenesis of the histamine-binding site of the histamine H4 receptor. , 2002, Molecular pharmacology.
[125] John Dunlop,et al. The role of transmembrane helix 5 in agonist binding to the human H3 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.
[126] F. Di Virgilio,et al. Expression and function of histamine receptors in human monocyte-derived dendritic cells. , 2002, The Journal of allergy and clinical immunology.
[127] T. Bürckstümmer,et al. The human histamine H2‐receptor couples more efficiently to Sf9 insect cell Gs‐proteins than to insect cell Gq‐proteins: limitations of Sf9 cells for the analysis of receptor/Gq‐protein coupling , 2002, Journal of neurochemistry.
[128] M. Trevethick,et al. IDENTIFICATION OF A HISTAMINE H4 RECEPTOR ON HUMAN EOSINOPHILS—ROLE IN EOSINOPHIL CHEMOTAXIS , 2002, Journal of receptor and signal transduction research.
[129] T. Bürckstümmer,et al. Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. , 2001, Molecular pharmacology.
[130] R. Seifert,et al. Similar apparent constitutive activity of human histamine H(2)-receptor fused to long and short splice variants of G(salpha). , 2001, The Journal of pharmacology and experimental therapeutics.
[131] A. Ortega,et al. Histamine H1 Receptor Activation Stimulates Mitogenesis in Human Astrocytoma U373 MG Cells , 2001, Journal of Neuro-Oncology.
[132] R. Leurs,et al. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling. , 2001, Molecular pharmacology.
[133] L B Hough,et al. Genomics meets histamine receptors: new subtypes, new receptors. , 2001, Molecular pharmacology.
[134] F. Monsma,et al. Cloning and characterization of a novel human histamine receptor. , 2001, The Journal of pharmacology and experimental therapeutics.
[135] C R Ganellin,et al. Distinct pharmacology of rat and human histamine H3 receptors: role of two amino acids in the third transmembrane domain , 2000, British journal of pharmacology.
[136] Y. Masuho,et al. Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes* , 2000, The Journal of Biological Chemistry.
[137] C. Ezeamuzie,et al. Histamine H2 receptors mediate the inhibitory effect of histamine on human eosinophil degranulation , 2000, British journal of pharmacology.
[138] C. Shayo,et al. Rapid desensitization and slow recovery of the cyclic AMP response mediated by histamine H(2) receptors in the U937 cell line. , 2000, Biochemical pharmacology.
[139] D. Cooper,et al. Characteristics of the Ca2+‐dependent inhibition of cyclic AMP accumulation by histamine and thapsigargin in human U373 MG astrocytoma cells , 2000, British journal of pharmacology.
[140] T. Yoshino,et al. Histamine Is a Potent Inducer of IL-18 and IFN-γ in Human Peripheral Blood Mononuclear Cells , 2000, The Journal of Immunology.
[141] R. Kühne,et al. Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists. , 2000, Journal of medicinal chemistry.
[142] R. Leurs,et al. Mutational Analysis of the Antagonist-binding Site of the Histamine H1 Receptor* , 1999, The Journal of Biological Chemistry.
[143] A. Hancock,et al. Analysis of Apparent Noncompetitive Responses to Competitive H1-Histamine Receptor Antagonists in Fluorescent Imaging Plate Reader-Based Calcium Assays , 1999, Journal of biomolecular screening.
[144] M. Jackson,et al. Cloning and functional expression of the human histamine H3 receptor. , 1999, Molecular pharmacology.
[145] S. Hishinuma,et al. Ca2+/Calmodulin‐Mediated Regulation of Agonist‐Induced Sequestration of Gq Protein‐Coupled Histamine H1 Receptors in Human U373 MG Astrocytoma Cells , 1998, Journal of neurochemistry.
[146] B. Kobilka,et al. Reconstitution of β2-adrenoceptor−GTP-binding-protein interaction in Sf9 cells , 1998 .
[147] B. Kobilka,et al. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor. , 1998, The Journal of biological chemistry.
[148] B. Kobilka,et al. Different Effects of Gsα Splice Variants on β2-Adrenoreceptor-mediated Signaling , 1998, The Journal of Biological Chemistry.
[149] D. Leopoldt,et al. G Proteins endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors , 1997, Naunyn-Schmiedeberg's Archives of Pharmacology.
[150] C. Shayo,et al. Histamine modulates the expression of c-fos through cyclic AMP production via the H2 receptor in the human promonocytic cell line U937. , 1997, Molecular pharmacology.
[151] T. Gudermann,et al. G proteins of the Gq family couple the H2 histamine receptor to phospholipase C. , 1996, Molecular endocrinology.
[152] Paul H. J. Nederkoorn,et al. The agonistic binding site at the histamine H2 receptor. I. Theoretical investigations of histamine binding to an oligopeptide mimicking a part of the fifth transmembrane α-helix , 1996, J. Comput. Aided Mol. Des..
[153] M. V. Regenmortel,et al. Mapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity , 1996 .
[154] R. Seifert,et al. Receptor-independent G protein activation may account for the stimulatory effects of first-generation H1-receptor antagonists in HL-60 cells, basophils, and mast cells. , 1996, Biochemical pharmacology.
[155] G. Cohen,et al. Interactions of protein antigens with antibodies. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[156] R. Leurs,et al. Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists. , 1995, Biochemical and biophysical research communications.
[157] M. Garbarg,et al. Synthesis and histamine H1 receptor agonist activity of a series of 2-phenylhistamines, 2-heteroarylhistamines, and analogues. , 1995, Journal of medicinal chemistry.
[158] G. Schultz,et al. Histamine receptor-dependent and/or -independent activation of guanine nucleotide-binding proteins by histamine and 2-substituted histamine derivatives in human leukemia (HL-60) and human erythroleukemia (HEL) cells. , 1995, Biochemical pharmacology.
[159] R. Seifert,et al. Cationic-amphiphilic arpromidine-derived guanidines and a histamine trifluoromethyl-toluidide derivative may activate pertussis toxin-sensitive G-proteins by a receptor-independent mechanism , 1995, Naunyn-Schmiedeberg's Archives of Pharmacology.
[160] G. Baumann,et al. Haemodynamic profile of new H2-receptor agonists in congestive heart failure. , 1995, European journal of clinical investigation.
[161] G. Schultz,et al. The Drosophila cation channel trpl expressed in insect Sf9 cells is stimulated by agonists of G‐protein‐coupled receptors , 1995, FEBS letters.
[162] H Hayashi,et al. Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194. , 1994, Biochemical and biophysical research communications.
[163] C. Szpirer,et al. Stable expression of human H1-histamine-receptor cDNA in Chinese hamster ovary cells. Pharmacological characterisation of the protein, tissue distribution of messenger RNA and chromosomal localisation of the gene. , 1994, European journal of biochemistry.
[164] R. Leurs,et al. Pharmacological characterization of the human histamine H2 receptor stably expressed in Chinese hamster ovary cells , 1994, British journal of pharmacology.
[165] E. Schulman,et al. Pharmacologic characterization of a novel histamine receptor on human eosinophils. , 1994, American journal of respiratory and critical care medicine.
[166] P. Vanhoutte,et al. International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. , 1994, Pharmacological reviews.
[167] R. Leurs,et al. Site-directed mutagenesis of the histamine H1-receptor reveals a selective interaction of asparagine207 with subclasses of H1-receptor agonists. , 1994, Biochemical and biophysical research communications.
[168] G. Schultz,et al. Histamine H1-receptors in HL-60 monocytes are coupled to Gi-proteins and pertussis toxin-insensitive G-proteins and mediate activation of Ca2+ influx without concomitant Ca2+ mobilization from intracellular stores , 1994, Naunyn-Schmiedeberg’s Archives of Pharmacology.
[169] C. Dinarello,et al. Histamine enhances interleukin (IL)-1-induced IL-6 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. , 1994, The Journal of biological chemistry.
[170] G. Schultz,et al. The H1 receptor agonist 2-(3-chlorophenyl)histamine activates Gi proteins in HL-60 cells through a mechanism that is independent of known histamine receptor subtypes. , 1994, Molecular pharmacology.
[171] J. Young,et al. Calcium‐dependence of histamine‐ and carbachol‐induced inositol phosphate formation in human U373 MG astrocytoma cells: comparison with HeLa cells and brain slices , 1994, British journal of pharmacology.
[172] J. Leysen,et al. Genomic cloning, heterologous expression and pharmacological characterization of a human histamine H1 receptor. , 1993, Biochemical and biophysical research communications.
[173] C. Dinarello,et al. Histamine enhances interleukin (IL)-1-induced IL-1 gene expression and protein synthesis via H2 receptors in peripheral blood mononuclear cells. Comparison with IL-1 receptor antagonist. , 1993, The Journal of clinical investigation.
[174] J. Williams,et al. Protein kinase C inhibits cyclic adenosine monophosphate generation by histamine and truncated glucagon like peptide 1 in the human gastric cancer cell line HGT-1. , 1993, Gut.
[175] Yi-Jun Guo,et al. Molecular basis for the interaction of histamine with the histamine H2 receptor. , 1992, The Journal of biological chemistry.
[176] R. Leurs,et al. Short‐term desensitization of the histamine H1 receptor in human HeLa cells: involvement of protein kinase C dependent and independent pathways , 1992, British journal of pharmacology.
[177] H. Timmerman,et al. Histamine H2-receptor agonists. Synthesis, in vitro pharmacology, and qualitative structure-activity relationships of substituted 4- and 5-(2-aminoethyl)thiazoles. , 1992, Journal of medicinal chemistry.
[178] R. Seifert,et al. Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation. , 1992, Molecular pharmacology.
[179] R. Seifert,et al. Histamine increases cytosolic Ca2+ in dibutyryl-cAMP-differentiated HL-60 cells via H1 receptors and is an incomplete secretagogue. , 1992, Molecular pharmacology.
[180] E. Schulman,et al. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. , 1992, Journal of immunology.
[181] J. Ballesteros,et al. Analysis and refinement of criteria for predicting the structure and relative orientations of transmembranal helical domains. , 1992, Biophysical journal.
[182] T. Yamada,et al. Molecular cloning of the human histamine H2 receptor. , 1991, Biochemical and biophysical research communications.
[183] Y. Hattori,et al. Identification and characterization of histamine H1‐ and H2‐receptors in guinea‐pig left atrial membranes by [3H]‐mepyramine and [3H]‐tiotidine binding , 1991, British journal of pharmacology.
[184] T. Chiba,et al. Presence of histamine H2-receptors on human gastric carcinoma cell line MKN-45 and their increase by retinoic acid treatment. , 1991, Biochemical and biophysical research communications.
[185] R. Seifert,et al. Characterization of histamine H2-receptors in human neutrophils with a series of guanidine analogues of impromidine , 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.
[186] I. Verlaan,et al. Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors , 1990, The Journal of cell biology.
[187] G. Schultz,et al. Histamine inhibits activation of human neutrophils and HL-60 leukemic cells via H2-receptors , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.
[188] M. Mitsuhashi,et al. Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells. , 1989, The Journal of biological chemistry.
[189] R. Cramer,et al. Validation of the general purpose tripos 5.2 force field , 1989 .
[190] A. Buschauer. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs. , 1989, Journal of medicinal chemistry.
[191] C. Gespach,et al. Pharmacology of histamine H2 receptor antagonists in the human gastric cancer cell line HGT-1. Structure-activity relationship of isocytosine-furan and imidazole derivatives related to cimetidine. , 1986, Biochemical pharmacology.
[192] J. Abita,et al. Histamine H2 receptor activity during the differentiation of the human monocytic‐like cell line U‐937 , 1985, FEBS letters.
[193] C. Gespach,et al. Desensitization by histamine of H2 receptor‐mediated adenylate cyclase activation in the human gastric cancer cell line HGT‐1 , 1984, FEBS letters.
[194] C. L. Johnson,et al. Histamine H2 receptor desensitization in HL-60 human promyelocytic leukemia cells. , 1984, The Journal of pharmacology and experimental therapeutics.
[195] C. Gespach,et al. Irreversible and specific inactivation by AH 22216 of histamine H2 receptors in the human gastric cancer cell line HGT-1. , 1983, Biochemical and biophysical research communications.
[196] B. Seligmann,et al. Histamine modulation of human neutrophil oxidative metabolism, locomotion, degranulation, and membrane potential changes. , 1983, Journal of immunology.
[197] J. Abita,et al. Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils. , 1982, Molecular pharmacology.
[198] C. Laboisse,et al. Characterization of a newly established human gastric cancer cell line HGT-1 bearing histamine H2-receptors. , 1982, Cancer research.
[199] W. Duncan,et al. Impromidine (SK&F 92676) is a very potent and specific agonist for histamine H2 receptors , 1978, Nature.
[200] W. Busse,et al. Decreased H2 histamine response of granulocytes of asthmatic patients. , 1977, The Journal of clinical investigation.
[201] W. Busse,et al. Histamine inhibition of neutrophil lysosomal enzyme release: an H2 histamine receptor response. , 1976, Science.
[202] J. Black,et al. Definition and Antagonism of Histamine H2-receptors , 1972, Nature.
[203] Hans-Joachim Wittmann,et al. Species-dependent activities of G-protein-coupled receptor ligands: lessons from histamine receptor orthologs. , 2013, Trends in pharmacological sciences.
[204] S. Hishinuma,et al. The affinity of histamine for Gq protein-coupled histamine H(1)-receptors is predominantly regulated by their internalization in human astrocytoma cells. , 2012, Journal of pharmacological sciences.
[205] J. Ortonne. Urticaria and its subtypes: the role of second-generation antihistamines. , 2012, European journal of internal medicine.
[206] C. Perry,et al. Histamine Dihydrochloride , 2012, Drugs.
[207] R. Gutzmer,et al. Human memory Th17 cells express a functional histamine H4 receptor. , 2012, The American journal of pathology.
[208] G. Reynolds,et al. Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms. , 2010, Pharmacology and Therapeutics.
[209] R. Seifert,et al. Coexpression systems as models for the analysis of constitutive GPCR activity. , 2010, Methods in enzymology.
[210] R. Seifert,et al. Fusion proteins as model systems for the analysis of constitutive GPCR activity. , 2010, Methods in enzymology.
[211] J. Mullol,et al. Allergic conjunctivitis and H1 antihistamines. , 2009, Journal of investigational allergology & clinical immunology.
[212] S. Hishinuma,et al. Intact cell binding for in vitro prediction of sedative and non-sedative histamine H1-receptor antagonists based on receptor internalization. , 2008, Journal of pharmacological sciences.
[213] Erwin W. Gelfand,et al. The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines , 2008, Nature Reviews Drug Discovery.
[214] T. Kuroki,et al. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis. , 2008, Progress in brain research.
[215] P. Desai,et al. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus. , 2007, The Journal of allergy and clinical immunology.
[216] R. Seifert,et al. Stimulation of histamine H2- (and H1)-receptors activates Ca2+ influx in all-atrans-retinoic acid-differentiated HL-60 cells independently of phospholipase C or adenylyl cyclase , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.
[217] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[218] J. Schwartz,et al. Novel Histamine H3‐Receptor Antagonists with Benzyl Ether Structure or Related Moieties: Synthesis and Structure‐Activity Relationships , 1996, Archiv der Pharmazie.
[219] J. Abita,et al. Human polymorphonuclear neutrophils. Pharmacological characterization of histamine receptors mediating the elevation of cyclic AMP. , 1982, Molecular pharmacology.
[220] R. Thurmond,et al. Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Pharmacological Characterization of Oxime Agonists of the Histamine H 4 Receptor , 2022 .